首页> Neurobiology of aging> Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrum.

Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer's disease spectrum.

导出 LinkOut

翻译打印收藏纠错

第一作者： Avinash,Chandra

第一单位： Neurodegeneration Imaging Group, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.

作者： Avinash,Chandra ^[1] ; Chloe,Farrell ^[1] ; Heather,Wilson ^[2] ; George,Dervenoulas ^[3] ; Edoardo Rosario,De Natale ^[2] ; Marios,Politis ^[4] ; Alzheimer's Disease Neuroimaging Initiative

作者单位： Neurodegeneration Imaging Group, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK. ^[1] Neurodegeneration Imaging Group, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK; Neurodegeneration Imaging Group, University of Exeter Medical School, London, UK. ^[2] Neurodegeneration Imaging Group, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK; Department of Neurology, Queen Elizabeth Hospital, Lewisham and Greenwich NHS Trust, London, UK. ^[3] Neurodegeneration Imaging Group, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK; Neurodegeneration Imaging Group, University of Exeter Medical School, London, UK. Electronic address: m.politis@exeter.ac.uk. ^[4]

关键词 Alzheimer's disease Amyloid-β Aquaporin-4 Glymphatic system Mild cognitive impairment